SCHEMBL4584948

SCHEMBL4584948

COc1ccc(-c2nc(N)c(C(N)=O)nc2-c2ccc(=O)n(C(C)C)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.47
ADORA1 P30542 1/20 0.47
IKBKB O14920 1/20 0.44
ALDH1A1 P00352 1/20 0.42
GAA P10253 1/20 0.42
MAPKAPK2 P49137 2/20 0.39
SRC P12931 4/20 0.39
FGFR1 P11362 1/20 0.39
FGFR2 P21802 1/20 0.39
FGFR4 P22455 1/20 0.39
FGFR3 P22607 1/20 0.39
PIK3CD O00329 1/20 0.38
ABL1 P00519 1/20 0.38
EGFR P00533 1/20 0.38
HCK P08631 1/20 0.38
KDR P35968 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
MTOR P42345 1/20 0.38
PIK3CG P48736 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4586459 0.91 ADORA2A (0.47) ADORA2AADORA1IKBKBALDH1A1GAA
SCHEMBL4584451 0.89 IKBKB (0.47) ADORA2AADORA1IKBKBSRCPIK3CD
SCHEMBL4584074 0.87 ADORA2A (0.50) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4585198 0.87 ADORA2A (0.47) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4584010 0.86 ADORA2A (0.64) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4584898 0.86 ADORA2A (0.49) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4585807 0.86 ADORA2A (0.49) ADORA2AADORA1IKBKBALDH1A1SRC
SCHEMBL4583807 0.85 ADORA2A (0.44) ADORA2AADORA1IKBKBALDH1A1GAA
SCHEMBL4584203 0.83 ADORA2A (0.47) ADORA2AADORA1KDRBMPR1BBMPR1A
SCHEMBL4583849 0.83 ADORA2A (0.54) ADORA2AADORA1BMPR1BBMPR1ATGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7407961-B2 Pyrazine derivatives and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2008-08-05 US disclosed
US-20050113387-A1 Pyrazine derivatives and pharmaceutical use thereof FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2005-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113387-A1 Pyrazine derivatives and pharmaceutical use thereof ADORA2A, P2RX5, ADORA1 ADORA2A 1/4885ADORA1 3/4885IKBKB 3409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.